The FASEB Journal, Vol 3, 1593-1599, Copyright © 1989 by The Federation of American Societies for Experimental Biology

REVIEWS

Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly

F Cabral and SB Barlow
Department of Pharmacology, University of Texas Medical School, Houston 77225.

The development of resistance in mammalian cells to toxic drugs is a significant clinical problem, especially in cancer chemotherapy where drug-resistant tumor cells often prove to be refractory to treatment. In this article, we review some of the basic mechanisms of drug resistance from the perspective of a single cell bathed in medium containing the drug. These mechanisms may be categorized according to changes in the cell that affect the ability of the drug to accumulate intracellularly, changes in enzymes that are required for drug toxicity, alterations in trapping of the drug or detoxification of the drug, alterations in binding to an intracellular target, or alterations in cellular processes that compensate for the action of the drug. This latter mechanism is illustrated in some depth by discussing mutants of Chinese hamster ovary cells that are resistant to the effects of drugs that interfere with microtubule assembly.

This article has been cited by other articles:

				C. Munoz-Fontela, L. Marcos-Villar, F. Hernandez, P. Gallego, E. Rodriguez, J. Arroyo, S.-J. Gao, J. Avila, and C. Rivas Induction of Paclitaxel Resistance by the Kaposi's Sarcoma-Associated Herpesvirus Latent Protein LANA2 J. Virol., February 1, 2008; 82(3): 1518 - 1525. [Abstract] [Full Text] [PDF]

				P. Fanara, S. Turner, R. Busch, S. Killion, M. Awada, H. Turner, A. Mahsut, K. L. LaPrade, J. M. Stark, and M. K. Hellerstein In Vivo Measurement of Microtubule Dynamics Using Stable Isotope Labeling with Heavy Water: EFFECT OF TAXANES J. Biol. Chem., November 26, 2004; 279(48): 49940 - 49947. [Abstract] [Full Text] [PDF]

				M. Hari, Y. Wang, S. Veeraraghavan, and F. Cabral Mutations in {alpha}- and {beta}-Tubulin That Stabilize Microtubules and Confer Resistance to Colcemid and Vinblastine Mol. Cancer Ther., July 1, 2002; 2(7): 597 - 605. [Abstract] [Full Text] [PDF]

				S. B. Barlow, M. L. Gonzalez-Garay, and F. Cabral Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis J. Cell Sci., January 9, 2002; 115(17): 3469 - 3478. [Abstract] [Full Text] [PDF]

				M. L. Gonzalez-Garay, L. Chang, K. Blade, D. R. Menick, and F. Cabral A beta -Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance J. Biol. Chem., August 20, 1999; 274(34): 23875 - 23882. [Abstract] [Full Text] [PDF]

				C. Dumontet and B. I. Sikic Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death J. Clin. Oncol., March 1, 1999; 17(3): 1061 - 1061. [Abstract] [Full Text] [PDF]

				K Blade, D. Menick, and F Cabral Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel J. Cell Sci., January 7, 1999; 112(13): 2213 - 2221. [Abstract] [PDF]

				P. Giannakakou, D. L. Sackett, Y.-K. Kang, Z. Zhan, J. T. M. Buters, T. Fojo, and M. S. Poruchynsky Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant beta -Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization J. Biol. Chem., July 4, 1997; 272(27): 17118 - 17125. [Abstract] [Full Text] [PDF]